Source link : https://newshealth.biz/health-news/ozempic-shows-benefit-in-type-1-diabetes-patients-with-obesity/
(MedPage Today) — CHICAGO — Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% who received 1 mg of the… Source link : https://www.medpagetoday.com/meetingcoverage/ada/116206 Author : Publish date : 2025-06-23 20:15:00 Copyright for syndicated content belongs […]
The post Ozempic Shows Benefit in Type 1 Diabetes Patients With Obesity first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-23 20:15:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8